Wilterding Mark has filed 5 insider transactions across 1 company since January 2026.
Most recent transaction: a option exercise of 20441 shares of RxSight, Inc. ($RXST) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | RxSight, Inc. | $RXST | Wilterding Mark | Chief Financial Officer | M | Common Stock | 20441 | $0.00 | 20,441.0000 | 41,116,640 | 9999.99% | 0.05% |
| Feb. 28, 2026 | RxSight, Inc. | $RXST | Wilterding Mark | Chief Financial Officer | F | Common Stock | 8068 | $7.61 | 12,373.0000 | 41,116,640 | 39.47% | 0.02% |
| Feb. 28, 2026 | RxSight, Inc. | $RXST | Wilterding Mark | Chief Financial Officer | M | Restricted Stock Unit | 20441 | $0.00 | 143,087.0000 | 41,116,640 | 12.50% | 0.05% |
| Jan. 12, 2026 | RxSight, Inc. | $RXST | Wilterding Mark | Chief Financial Officer | A | Stock Option (right to buy) | 258770 | $0.00 | 258,770.0000 | 41,116,640 | 9999.99% | 0.63% |
| Jan. 12, 2026 | RxSight, Inc. | $RXST | Wilterding Mark | Chief Financial Officer | A | Restricted Stock Unit | 163528 | $0.00 | 163,528.0000 | 41,116,640 | 9999.99% | 0.40% |